PPARG and lung carcinoma: For example, a number of studies have suggested anti-estrogen therapy as a lung cancer therapeutic [37]–[40], and in a mouse lung cancer study, the use of a PPARγ agonist had a synergistic effect in reducing tumor burden when used with cis-platinum [41].